Sero Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.75 M
- Company Age 39 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.58 Cr
- Revenue Growth -50.36%
- Profit Growth -108.45%
- Ebitda -452.54%
- Net Worth -2.20%
- Total Assets -1.47%
About Sero Diagnostics
Sero Diagnostics Pvt Ltd (SDPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 December 1985 and has a history of 39 years and one month. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company has closed loans amounting to ₹8.58 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dhanisha Garg and Ravikant Garg serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U15143MH1985PTC038490
- Company No.
038490
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 1985
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sero Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhanisha Garg  | Director | 20-Dec-2013 | Current |
| Ravikant Garg | Director | 10-Feb-1992 | Current |
Financial Performance of Sero Diagnostics.
Sero Diagnostics Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 50.36% decrease. The company also saw a substantial fall in profitability, with a 108.45% decrease in profit. The company's net worth dipped by a decrease of 2.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sero Diagnostics?
Unlock access to Sero Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹85.80 M
Charges Breakdown by Lending Institutions
- The Shamrao Vithal Co-Operative Bank Ltd : 8.58 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2010 | The Shamrao Vithal Co-Operative Bank Ltd | ₹8.58 Cr | Satisfied |
How Many Employees Work at Sero Diagnostics?
Unlock and access historical data on people associated with Sero Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sero Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sero Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
